Dithranol (Synonyms: ジスラノール; Anthralin)

Name: Dithranol
Brand: MedChemExpress
SKU: HY-B0738
Rating: 4.5 (0 reviews)

製品番号: HY-B0738 純度: 95.26%: Data Sheet SDS COA 取扱説明書
FAQs
Technical Support

Dithranol (Anthralin) is an anthraquinone derivative, with potent anti-psoriatic effects. Dithranol can inhibit DNA replication and repair.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

Dithranol 構造式

CAS 番号 : 1143-38-0

容量	価格（税別）	在庫状況	数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	USD 46	在庫あり	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	USD 46	在庫あり	Estimated Time of Arrival: December 31
Solid
50 mg	$42	在庫あり	Estimated Time of Arrival: December 31
100 mg	$66	在庫あり	Estimated Time of Arrival: December 31
250 mg	$115	在庫あり	Estimated Time of Arrival: December 31
500 mg	$144	在庫あり	Estimated Time of Arrival: December 31
1 g		お問い合わせ
5 g		お問い合わせ

or バルクお問い合わせ

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 0 publication(s) in Google Scholar

Other Forms of Dithranol:

Dithranol (Standard) お問い合わせ

DNA/RNA Synthesis アイソフォーム固有の製品をすべて表示:

すべてのアイソフォームを表示

RNASE L DNA Polymerases RNA Polymerases Helicases DNA Ligase

生物活性
純度とドキュメンテーション
参考文献
カスタマーレビュー

製品説明

Dithranol (Anthralin) is an anthraquinone derivative, with potent anti-psoriatic effects. Dithranol can inhibit DNA replication and repair^[1]^[2].

Cellular Effect

Cell Line	Type	Value	Description	References
HaCaT	IC₅₀	0.7 3 Compound: Anthralin	Antihyperproliferative activity against human HaCaT cells after 48 hrs by MTT assay Antihyperproliferative activity against human HaCaT cells after 48 hrs by MTT assay	[PMID: 28410493]
HaCaT	GI₅₀	0.7 3 Compound: 14	Growth inhibition of human HaCaT cells after 72 hrs by neutral red uptake assay Growth inhibition of human HaCaT cells after 72 hrs by neutral red uptake assay	[PMID: 22944332]
HaCaT	GI₅₀	0.7 3 Compound: 14	Growth inhibition of human HaCaT cells after 72 hrs by neutral red uptake assay Growth inhibition of human HaCaT cells after 72 hrs by neutral red uptake assay	[PMID: 22944332]
HaCaT	IC₅₀	0.7 3 Compound: Anthralin	Antihyperproliferative activity against human HaCaT cells after 48 hrs by MTT assay Antihyperproliferative activity against human HaCaT cells after 48 hrs by MTT assay	[PMID: 28410493]
HaCaT	IC₅₀	0.7 3 Compound: 2, Anthralin	Antiproliferative activity against human HaCaT cells assessed as dispersed cells after 48 hrs by phase-contrast microscopic analysis Antiproliferative activity against human HaCaT cells assessed as dispersed cells after 48 hrs by phase-contrast microscopic analysis	[PMID: 20850910]
HaCaT	IC₅₀	0.7 3 Compound: 2	Antihyperproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopic analysis Antihyperproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopic analysis	[PMID: 26840368]
HaCaT	IC₅₀	0.7 3 Compound: 1	Antiproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy Antiproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy	[PMID: 20828887]
HaCaT	IC₅₀	0.7 3 Compound: 3	Antihyperproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy Antihyperproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy	[PMID: 22845014]
HEK293	GI₅₀	0.5 3 Compound: 14	Growth inhibition of human NHEK cells after 72 hrs by neutral red uptake assay Growth inhibition of human NHEK cells after 72 hrs by neutral red uptake assay	[PMID: 22944332]
HaCaT	IC₅₀	0.7 3 Compound: 1	Antiproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy Antiproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy	[PMID: 20452101]
HaCaT	IC₅₀	0.7 3 Compound: 5	Antihyperproliferative activity against human HaCaT cells assessed as inhibition of cell growth after 48 hrs by phase contrast microscopy Antihyperproliferative activity against human HaCaT cells assessed as inhibition of cell growth after 48 hrs by phase contrast microscopy	[PMID: 24964246]
HaCaT	IC₅₀	0.6 3 Compound: 1/ Anthralin	Antiproliferative (inhibition of cell growth) activity against HaCaT cells (human keratinocyte line) Antiproliferative (inhibition of cell growth) activity against HaCaT cells (human keratinocyte line)	[PMID: 9371243]
HaCaT	IC₅₀	0.7 3 Compound: 2	Antihyperproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopic analysis Antihyperproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopic analysis	[PMID: 26840368]
HaCaT	IC₅₀	0.7 3 Compound: 5	Antihyperproliferative activity against human HaCaT cells assessed as inhibition of cell growth after 48 hrs by phase contrast microscopy Antihyperproliferative activity against human HaCaT cells assessed as inhibition of cell growth after 48 hrs by phase contrast microscopy	[PMID: 24964246]
HaCaT	IC₅₀	0.6 3 Compound: anthralin	Antiproliferative activity (AA) against HaCaT keratinocytes. Antiproliferative activity (AA) against HaCaT keratinocytes.	[PMID: 9276024]
HaCaT	IC₅₀	0.7 3 Compound: 3	Antihyperproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy Antihyperproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy	[PMID: 22845014]
HaCaT	IC₅₀	0.7 3 Compound: Anthralin	Antiproliferative activity against growth of HaCaT cell was determined Antiproliferative activity against growth of HaCaT cell was determined	[PMID: 11140730]
HaCaT	IC₅₀	0.2 3 Compound: anthralin	Antiproliferative activity against HaCaT cells Antiproliferative activity against HaCaT cells	[PMID: 8201600]
HaCaT	IC₅₀	0.945 3 Compound: 1; DTR; dithranol	Antiproliferative activity against human HaCaT cells after 24 hrs by MTT assay Antiproliferative activity against human HaCaT cells after 24 hrs by MTT assay	[PMID: 26515039]
HaCaT	IC₅₀	2.9 3 Compound: anthralin	Antiproliferative activity against human HaCaT cells assessed as [3H]thymidine incorporation after 24 hrs Antiproliferative activity against human HaCaT cells assessed as [3H]thymidine incorporation after 24 hrs	[PMID: 15387642]
HaCaT	IC₅₀	0.7 3 Compound: 1; DTR; dithranol	Antiproliferative activity against human HaCaT cells Antiproliferative activity against human HaCaT cells	[PMID: 26515039]
HaCaT	IC₅₀	0.7 3 Compound: Anthralin	Antiproliferative activity against human HaCaT cells Antiproliferative activity against human HaCaT cells	[PMID: 10479319]
HEK293	GI₅₀	0.5 3 Compound: 14	Growth inhibition of human NHEK cells after 72 hrs by neutral red uptake assay Growth inhibition of human NHEK cells after 72 hrs by neutral red uptake assay	[PMID: 22944332]
HaCaT	IC₅₀	0.7 3 Compound: anthralin	Antiproliferative activity against human HaCaT cells Antiproliferative activity against human HaCaT cells	[PMID: 10395495]
THP-1	GI₅₀	54 3 Compound: 14	Growth inhibition of human THP1 cells after 72 hrs by Cell Titer 96 aqueous one solution assay Growth inhibition of human THP1 cells after 72 hrs by Cell Titer 96 aqueous one solution assay	[PMID: 22944332]
U-937	GI₅₀	5 3 Compound: 14	Growth inhibition of human U937 cells after 72 hrs by Cell Titer 96 aqueous one solution assay Growth inhibition of human U937 cells after 72 hrs by Cell Titer 96 aqueous one solution assay	[PMID: 22944332]
HaCaT	IC₅₀	0.945 3 Compound: 1; DTR; dithranol	Antiproliferative activity against human HaCaT cells after 24 hrs by MTT assay Antiproliferative activity against human HaCaT cells after 24 hrs by MTT assay	[PMID: 26515039]
HaCaT	IC₅₀	0.7 3 Compound: 1	Antiproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy Antiproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy	[PMID: 20452101]
HaCaT	IC₅₀	0.7 3 Compound: 1	Antiproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy Antiproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy	[PMID: 20828887]
HaCaT	IC₅₀	2.9 3 Compound: anthralin	Antiproliferative activity against human HaCaT cells assessed as [3H]thymidine incorporation after 24 hrs Antiproliferative activity against human HaCaT cells assessed as [3H]thymidine incorporation after 24 hrs	[PMID: 15387642]
HaCaT	IC₅₀	0.7 3 Compound: 2, Anthralin	Antiproliferative activity against human HaCaT cells assessed as dispersed cells after 48 hrs by phase-contrast microscopic analysis Antiproliferative activity against human HaCaT cells assessed as dispersed cells after 48 hrs by phase-contrast microscopic analysis	[PMID: 20850910]
HaCaT	IC₅₀	0.7 3 Compound: 1	Concentration required to inhibit 50% growth of HaCaT cells Concentration required to inhibit 50% growth of HaCaT cells	[PMID: 11262091]
HaCaT	IC₅₀	0.7 3 Compound: 1	In vitro for antiproliferate activity against HaCaT cells In vitro for antiproliferate activity against HaCaT cells	[PMID: 9873705]
HEK293	GI₅₀	0.5 3 Compound: 14	Growth inhibition of human NHEK cells after 72 hrs by neutral red uptake assay Growth inhibition of human NHEK cells after 72 hrs by neutral red uptake assay	[PMID: 22944332]
HaCaT	GI₅₀	0.7 3 Compound: 14	Growth inhibition of human HaCaT cells after 72 hrs by neutral red uptake assay Growth inhibition of human HaCaT cells after 72 hrs by neutral red uptake assay	[PMID: 22944332]
PMNL	IC₅₀	37 3 Compound: anthralin	Inhibition of LTB4 biosynthesis in A-23187-stimulated bovine PMNL cells Inhibition of LTB4 biosynthesis in A-23187-stimulated bovine PMNL cells	[PMID: 10395494]
THP-1	GI₅₀	54 3 Compound: 14	Growth inhibition of human THP1 cells after 72 hrs by Cell Titer 96 aqueous one solution assay Growth inhibition of human THP1 cells after 72 hrs by Cell Titer 96 aqueous one solution assay	[PMID: 22944332]
HaCaT	IC₅₀	0.2 3 Compound: anthralin	Antiproliferative activity against HaCaT cells Antiproliferative activity against HaCaT cells	[PMID: 8201600]
U-937	GI₅₀	5 3 Compound: 14	Growth inhibition of human U937 cells after 72 hrs by Cell Titer 96 aqueous one solution assay Growth inhibition of human U937 cells after 72 hrs by Cell Titer 96 aqueous one solution assay	[PMID: 22944332]
HaCaT	IC₅₀	0.6 3 Compound: 1/ Anthralin	Antiproliferative (inhibition of cell growth) activity against HaCaT cells (human keratinocyte line) Antiproliferative (inhibition of cell growth) activity against HaCaT cells (human keratinocyte line)	[PMID: 9371243]
HaCaT	IC₅₀	0.6 3 Compound: anthralin	Antiproliferative activity (AA) against HaCaT keratinocytes. Antiproliferative activity (AA) against HaCaT keratinocytes.	[PMID: 9276024]
HaCaT	IC₅₀	0.7 3 Compound: 1	Concentration required to inhibit 50% growth of HaCaT cells Concentration required to inhibit 50% growth of HaCaT cells	[PMID: 11262091]
HaCaT	IC₅₀	0.7 3 Compound: 1	Antiproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy Antiproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy	[PMID: 20452101]
HaCaT	IC₅₀	0.7 3 Compound: 1	Antiproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy Antiproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy	[PMID: 20828887]
HaCaT	IC₅₀	0.7 3 Compound: 1	In vitro for antiproliferate activity against HaCaT cells In vitro for antiproliferate activity against HaCaT cells	[PMID: 9873705]
HaCaT	IC₅₀	0.7 3 Compound: 1; DTR; dithranol	Antiproliferative activity against human HaCaT cells Antiproliferative activity against human HaCaT cells	[PMID: 26515039]
HaCaT	IC₅₀	0.7 3 Compound: 2	Antihyperproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopic analysis Antihyperproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopic analysis	[PMID: 26840368]
HaCaT	IC₅₀	0.7 3 Compound: 2, Anthralin	Antiproliferative activity against human HaCaT cells assessed as dispersed cells after 48 hrs by phase-contrast microscopic analysis Antiproliferative activity against human HaCaT cells assessed as dispersed cells after 48 hrs by phase-contrast microscopic analysis	[PMID: 20850910]
HaCaT	IC₅₀	0.7 3 Compound: 3	Antihyperproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy Antihyperproliferative activity against human HaCaT cells after 48 hrs by phase contrast microscopy	[PMID: 22845014]
HaCaT	IC₅₀	0.7 3 Compound: 5	Antihyperproliferative activity against human HaCaT cells assessed as inhibition of cell growth after 48 hrs by phase contrast microscopy Antihyperproliferative activity against human HaCaT cells assessed as inhibition of cell growth after 48 hrs by phase contrast microscopy	[PMID: 24964246]
HaCaT	IC₅₀	0.7 3 Compound: Anthralin	Antiproliferative activity against human HaCaT cells Antiproliferative activity against human HaCaT cells	[PMID: 10479319]
HaCaT	IC₅₀	0.7 3 Compound: Anthralin	Antiproliferative activity against growth of HaCaT cell was determined Antiproliferative activity against growth of HaCaT cell was determined	[PMID: 11140730]
HaCaT	IC₅₀	0.7 3 Compound: Anthralin	Antihyperproliferative activity against human HaCaT cells after 48 hrs by MTT assay Antihyperproliferative activity against human HaCaT cells after 48 hrs by MTT assay	[PMID: 28410493]
HaCaT	IC₅₀	0.7 3 Compound: anthralin	Antiproliferative activity against human HaCaT cells Antiproliferative activity against human HaCaT cells	[PMID: 10395495]
HaCaT	IC₅₀	0.945 3 Compound: 1; DTR; dithranol	Antiproliferative activity against human HaCaT cells after 24 hrs by MTT assay Antiproliferative activity against human HaCaT cells after 24 hrs by MTT assay	[PMID: 26515039]
HaCaT	IC₅₀	2.9 3 Compound: anthralin	Antiproliferative activity against human HaCaT cells assessed as [3H]thymidine incorporation after 24 hrs Antiproliferative activity against human HaCaT cells assessed as [3H]thymidine incorporation after 24 hrs	[PMID: 15387642]
HaCaT	IC₅₀	3.52 3 Compound: Anthralin	Antiproliferative activity against human HaCaT cells incubated for 48 hrs by MTT assay Antiproliferative activity against human HaCaT cells incubated for 48 hrs by MTT assay	[PMID: 39151117]
PMNL	IC₅₀	37 3 Compound: anthralin	Inhibition of LTB4 biosynthesis in A-23187-stimulated bovine PMNL cells Inhibition of LTB4 biosynthesis in A-23187-stimulated bovine PMNL cells	[PMID: 10395494]
THP-1	GI₅₀	54 3 Compound: 14	Growth inhibition of human THP1 cells after 72 hrs by Cell Titer 96 aqueous one solution assay Growth inhibition of human THP1 cells after 72 hrs by Cell Titer 96 aqueous one solution assay	[PMID: 22944332]
U-937	GI₅₀	5 3 Compound: 14	Growth inhibition of human U937 cells after 72 hrs by Cell Titer 96 aqueous one solution assay Growth inhibition of human U937 cells after 72 hrs by Cell Titer 96 aqueous one solution assay	[PMID: 22944332]

体外実験

Dithranol (1.1 μM) inhibits replication in T98G cells by 50%^[2].
? Dithranol (0.1-0.5 μg/mL; 2-4 hours) increases the mRNA production of interleukin-10 receptors in a concentration dependent manner in HaCaT cells^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

RT-PCR^[3]

Cell Line:	HaCaT cells
Concentration:	0.1 μg/mL, 0.25 μg/mL, 0.5 μg/mL
Incubation Time:	2 hours, 4 hours
Result:	Increased the mRNA production of interleukin-10 receptors in HaCaT cells.

臨床実験

分子量

226.23

分子式

C₁₄H₁₀O₃

CAS 番号

1143-38-0

Appearance

Solid

Color

Yellow to orange

SMILES

O=C1C2=C(C=CC=C2O)CC3=CC=CC(O)=C13

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

溶剤 & 溶解度

体外:

DMSO : 20 mg/mL (88.41 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	4.4203 mL	22.1014 mL	44.2028 mL
5 mM	0.8841 mL	4.4203 mL	8.8406 mL
10 mM	0.4420 mL	2.2101 mL	4.4203 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

一般には略語で表示されます：C₁V₁ = C₂V₂

濃度 _（開始）

体積 _（開始）

濃度 _（終了）

体積 _（終了）

体内:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: 1 mg/mL (4.42 mM); Suspended solution; Need ultrasonic

This protocol yields a suspended solution of 1 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (10.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 1 mg/mL (4.42 mM); Suspended solution; Need ultrasonic

This protocol yields a suspended solution of 1 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (10.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 1 mg/mL (4.42 mM); Clear solution

This protocol yields a clear solution of ≥ 1 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (10.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

純度とドキュメンテーション

純度: ≥98.0%

Select Batch:

データシート (277 KB) SDS (396 KB)

COA (254 KB)

取扱説明書 (2659 KB)

参考文献

[1]. L Kemény , et al. Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris. Skin Pharmacol. 1990;3(1):1-20. [Content Brief]

[2]. J M Clark, et al. Inhibition of DNA replication and repair by anthralin or danthron in cultured human cells. J Invest Dermatol. 1982 Jul;79(1):18-22. [Content Brief]

[3]. A Farkas, et al. Dithranol upregulates IL-10 receptors on the cultured human keratinocyte cell line HaCaT. Inflamm Res. 2001 Jan;50(1):44-9. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	4.4203 mL	22.1014 mL	44.2028 mL	110.5070 mL
	5 mM	0.8841 mL	4.4203 mL	8.8406 mL	22.1014 mL
	10 mM	0.4420 mL	2.2101 mL	4.4203 mL	11.0507 mL
	15 mM	0.2947 mL	1.4734 mL	2.9469 mL	7.3671 mL
	20 mM	0.2210 mL	1.1051 mL	2.2101 mL	5.5254 mL
	25 mM	0.1768 mL	0.8841 mL	1.7681 mL	4.4203 mL
	30 mM	0.1473 mL	0.7367 mL	1.4734 mL	3.6836 mL
	40 mM	0.1105 mL	0.5525 mL	1.1051 mL	2.7627 mL
	50 mM	0.0884 mL	0.4420 mL	0.8841 mL	2.2101 mL
	60 mM	0.0737 mL	0.3684 mL	0.7367 mL	1.8418 mL
	80 mM	0.0553 mL	0.2763 mL	0.5525 mL	1.3813 mL

Dithranol Related Classifications

Inflammation/Immunology

Molarity Calculator
Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量		濃度		体積		分子量 *
	=		×		×

The dilution calculator equation

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

一般には略語で表示されます：C₁V₁ = C₂V₂

濃度 _（開始）	×	体積 _（開始）	=	濃度 _（終了）	×	体積 _（終了）
	×		=		×
C1		V1		C2		V2

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Dithranol1143-38-0AnthralinDNA/RNA SynthesispsoriaticplaquesDNAreplicationrepairInhibitorinhibitorinhibit

日本の代理先をお選びくださいナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
製品名			カスタマ需要量 *
お名前 *			タイトル
メールアドレス *			電話番号 *
デパートメント			組纖名 *
市区町村			都道府県
国或いは地域 *
必ず会社名を記載ください。個人への返信は行いません。
備考

製品名			Lot #
お名前 *			メールアドレス *
電話番号 *			部門 *
組纖名 *			国或いは地域 *
備考

Dithranol (Synonyms: ジスラノール; Anthralin)

カスタマーレビュー

Other Forms of Dithranol:

おすすめ

•関連スクリーニングライブラリ:

•関連小分子:

•関連タンパク質:

DNA/RNA Synthesis アイソフォーム固有の製品をすべて表示:

生物活性

純度とドキュメンテーション

参考文献

カスタマーレビュー

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Dithranol Related Classifications

Molarity Calculator

Dilution Calculator

The molarity calculator equation

The dilution calculator equation

Keywords:

最近チェックした製品:

お名前
メール *

	Sorry, but the email address you supplied was invalid.

Dithranol (Synonyms: ジスラノール; Anthralin)

カスタマーレビュー

Other Forms of Dithranol:

Dithranol 関連抗体

おすすめ

•関連スクリーニングライブラリ:

•関連小分子:

•関連タンパク質:

DNA/RNA Synthesis アイソフォーム固有の製品をすべて表示:

生物活性

純度とドキュメンテーション

参考文献

カスタマーレビュー

Dithranol 関連抗体

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Dithranol Related Classifications

Molarity Calculator

Dilution Calculator

The molarity calculator equation

The dilution calculator equation

Keywords:

最近チェックした製品:

カスタマーレビュー

Request for HNMR Report

Request for HNMR Report